Investors with a lot of money to spend have taken a bullish stance on Teva Pharmaceutical Indus TEVA. And retail traders should know. We noticed this today when the trades showed up on publicly ...

Teva Pharmaceutical Industries ( NYSE:TEVA ) Full Year 2024 Results Key Financial Results Revenue: US$16.5b (up 4.4... This pharma stock has made strong gains over the past 12 months thanks to its ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Healthcare lease accounting insights: How two organizations got compliant and stay audit-ready all year long Healthcare organizations (HCOs) often hold multiple leases such as those for real estate, ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

I've been on more than a dozen cruise ships in my lifetime, which has given me plenty of experience in determining what to ...

After hours: 8:00:00 p.m. EST ...